Efficacy and Safety of Pregabalin Prolonged Release-Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study.

Autor: Yeole AB; Supe Heart and Diabetes Hospital and Research Centre, Nashik, India., Sree Ranga Lakshmi G; Osmania General Hospital, Hyderabad, India., Selvakumar CJ; Kovai Diabetes Speciality Centre and Hospital, Coimbatore, India., Goni VG; Postgraduate Institute of Medical Education and Research, Chandigarh, India., Nawal CL; SMS Hospital, Jaipur, India., Valya BJ; Gandhi Hospital, Secunderabad, India., Patel BJ; Hi-Tech Multispeciality Hospital, Gandhinagar, India., Patel RD; Kanoria Hospital and Research Centre, Gandhinagar, India., Pawar ED; Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, India., Panigrahi R; Sparsh Hospital and Critical Care Pvt. Ltd, Bhubaneshwar, India., Kumar AY; King George's Medical College, Lucknow, India., Shintre SS; BJ Government Medical College and Sassoon General Hospitals, Pune, India., Devkare PH; Medical Affairs, Sun Pharmaceutical Industries Limited, Mumbai, India., Dharmadhikari SK; Medical Affairs, Sun Pharma Laboratories Limited, Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (East), Mumbai, 400063, Maharashtra, India., Choudhari SY; Medical Affairs, Sun Pharma Laboratories Limited, Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (East), Mumbai, 400063, Maharashtra, India. Sanjay.Choudhari@sunpharma.com., Doshi MS; India Clinical Research, Sun Pharma Laboratories Limited, Mumbai, India., Mehta SC; Medical Affairs, Sun Pharma Laboratories Limited, Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (East), Mumbai, 400063, Maharashtra, India., Joglekar SJ; Medical Affairs, Sun Pharmaceutical Industries Limited, Mumbai, India.

Publikováno v: Pain and therapy [Pain Ther] 2022 Dec; Vol. 11 (4), pp. 1451-1469. Date of Electronic Publication: 2022 Oct 12.